Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

Hepatology

Volumn 69, Issue 3, 2019, Pages 1020-1031

  Hofmeister, Megan G ^a   Rosenthal, Elizabeth M ^b   Barker, Laurie K ^a   Rosenberg, Eli S ^b   Barranco, Meredith A ^b   Hall, Eric W ^c   Edlin, Brian R ^d   Mermin, Jonathan ^d   Ward, John W ^a,e   Ryerson, A Blythe ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY AT ALBANY   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Program for Viral Hepatitis Elimination   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HOMELESS PERSON; HUMAN; NURSING HOME PATIENT; POPULATION SIZE; PREVALENCE; PRIORITY JOURNAL; SOLDIER; UNITED STATES; CHRONIC HEPATITIS C; NUTRITION; TIME FACTOR;

HEPATITIS C, CHRONIC; HUMANS; NUTRITION SURVEYS; PREVALENCE; TIME FACTORS; UNITED STATES;

EID: 85056099902     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.30297     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. Viral hepatitis surveillance, United States, 2016. https://www.cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf. Published April 2018. Accessed April 16, 2018.
2. Centers for Disease Control and Prevention. HIV surveillance report, 2016, vol. 28. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2017. Accessed February 26, 2018.
3. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology 2012;55:1652-1661.
4. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, et al. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009;361:580-593.
5. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014;370:1889-1898.
6. Ferenci P, Bernstein D, Lalezari J, Cohen D, Luo Y, Cooper C, et al. ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med 2014;370:1983-1992.
7. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014;61(Suppl.):S58-S68.
8. Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Harper AM, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant 2018;18(Suppl. 1):172-253.
9. Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising mortality associated with hepatitis C virus in the United States, 2003-2013. Clin Infect Dis 2016;62:1287-1288.
10. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed February 26, 2018.
11. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
12. Kruszon-Moran D, Paulose-Ram R, Denniston M, McQuillan G. Viral hepatitis among non-Hispanic Asian adults in the United States, 2011-2014. NCHS data brief, no. 225. Hyattsville, MD: National Center for Health Statistics; 2015.
13. Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology 2015;62:1353-1363.
14. US Census Bureau. The nation’s older population is still growing, Census Bureau reports. https://www.census.gov/newsroom/press-releases/2017/cb17-100.html. Published June 22, 2017. Accessed March 13, 2018.
15. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32.
16. Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health 2018;108:175-181.
17. Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National Health and Nutrition Examination Survey: sample design, 2011-2014. Vital Health Stat 2 2014;162:1-33.
18. Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013;62:362-365.
19. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: 2007-2012 data documentation, codebook, and frequencies. https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/SSHCV_E.htm. Published February 2015. Accessed May 1, 2018.
20. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: 2013-2014 data documentation, codebook, and frequencies. https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/SSHEPC_H.htm. Published January 2018. Accessed May 1, 2018.
21. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: 2015-2016 data documentation, codebook, and frequencies. https://wwwn.cdc.gov/Nchs/Nhanes/2015-2016/HEPC_I.htm. Published September 2017. Accessed May 1, 2018.
22. American Community Survey. 2012-2016 ACS 5-year estimates. https://www2.census.gov/programs-surveys/acs/summary_file/2016/data/. Accessed February 1, 2018.
23. Kaeble D, Cowhig M. Correctional populations in the United States, 2016. https://www.bjs.gov/content/pub/pdf/cpus16.pdf. Published April 2018. Accessed May 1, 2018.
24. US Department of Housing and Urban Development. PIT and HIC data since 2007. https://www.hudexchange.info/resource/3031/pit-and-hic-data-since-2007/. Published December 2017. Accessed February 1, 2018.
25. US Department of Defense. 2016 demographics: profile of the military community. https://download.militaryonesource.mil/12038/MOS/Reports/2016-Demographics-Report.pdf. Accessed June 1, 2018.
26. Harris-Kojetin L, Sengupta M, Park-Lee E, Valverde R, Caffrey C, Rome V, et al. Long-term care providers and services users in the United States: data from the National Study of Long-Term Care Providers, 2013-2014. VitalHealth Stat 3 2016;38:x-xii.
27. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011;31:1090-1101.
28. Borenstein M, Hedges LV, Higgins JPT, Rothstein H. Introduction to Meta-Analysis. 1st edn. Chichester, UK: Wiley; 2009.
29. Akiyama MJ, Kaba F, Rosner Z, Alper H, Holzman RS, MacDonald R. Hepatitis C screening of the “birth cohort” (born 1945-1965) and younger inmates of New York City jails. Am J Public Health 2016;106:1276-1277.
30. Cocoros N, Nettle E, Church D, Bourassa L, Sherwin V, Cranston K, et al. Screening for Hepatitis C as a Prevention Enhancement (SHAPE) for HIV: an integration pilot initiative in a Massachusetts County correctional facility. Public Health Rep 2014;129(Suppl. 1):5-11.
31. de la Flor C, Porsa E, Nijhawan AE. Opt-out HIV and hepatitis C testing at the Dallas County jail: uptake, prevalence, and demographic characteristics of testers. Public Health Rep 2017;132:617-621.
32. Kuncio DE, Newbern EC, Fernandez-Vina MH, Herdman B, Johnson CC, Viner KM. Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system. J Urban Health 2015;92:379-386.
33. Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, et al. Characterizing the burden of hepatitis C infection among entrants to Pennsylvania state prisons, 2004 to 2012. J Correct Health Care 2016;22:41-45.
34. Schoenbachler BT, Smith BD, Sena AC, Hilton A, Bachman S, Lunda M, et al. Hepatitis C virus testing and linkage to care in North Carolina and South Carolina jails, 2012-2014. Public Health Rep 2016;131(Suppl. 2):98-104.
35. Stockman LJ, Greer J, Holzmacher R, Dittmann B, Hoftiezer SA, Alsum LE, et al. Performance of risk-based and birth-cohort strategies for identifying hepatitis C virus infection among people entering prison, Wisconsin, 2014. Public Health Rep 2016;131:544-551.
36. Coyle C, Viner K, Hughes E, Kwakwa H, Zibbell JE, Vellozzi C, et al. Identification and linkage to care of HCV-infected persons in five health centers—Philadelphia, Pennsylvania, 2012-2014. MMWR Morb Mortal Wkly Rep 2015;64:459-463.
37. Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis 2014;59:1411-1419.
38. Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep 2015;64:453-458.
39. Koneru A, Nelson N, Hariri S, Canary L, Sanders KJ, Maxwell JF, et al. Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission—United States and Kentucky, 2011-2014. MMWR Morb Mortal Wkly Rep 2016;65:705-710.
40. Yehia BR, Schranz AJ, Umscheid CA, Lo Re V, 3rd. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One 2014;9:e101554.
41. Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Lu M, et al. Uptake of and factors associated with direct-acting antiviral therapy among patients in the Chronic Hepatitis Cohort Study, 2014 to 2015. J Clin Gastroenterol 2018;52:641-647.
42. Kanwal F, Kramer JR, El-Serag HB, Frayne S, Clark J, Cao Y, et al. Race and gender differences in the use of direct acting antiviral agents for hepatitis C virus. Clin Infect Dis 2016;63:291-299.
43. Belperio PS, Shahoumian TA, Mole LA, Backus LI. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals. Hepatology 2017;66:27-36.
44. LaMattina J. The VA will eliminate hepatitis C in veterans by year-end. https://www.forbes.com/sites/johnlamattina/2018/03/01/the-va-will-eliminate-hepatitis-c-in-veterans-by-year-end/#3f4e47dd7d12. Published March 1, 2018. Accessed March 9, 2018.
45. Mahajan R, Xing J, Liu SJ, Ly KN, Moorman AC, Rupp L, et al. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. Clin Infect Dis 2014;58:1055-1061.
46. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9:383-398.
47. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006;13:34-41.
48. Gilead Sciences, Inc. Q4 2016 earnings results. https://seekingalpha.com/article/4043560-gilead-sciences-inc-2016-q4-results-earnings-call-slides. Published February 7, 2017. Accessed March 29, 2018.
49. Chhatwal J, Chen Q, Aggarwal R. Estimation of hepatitis C disease burden and budget impact of treatment using health economic modeling. Infect Dis Clin North Am 2018;32:461-480.
50. Spaulding AC, Adee MG, Lawrence RT, Chhatwal J, von Oehsen W. Five questions concerning managing hepatitis C in the justice system: finding practical solutions for hepatitis C virus elimination. Infect Dis Clin North Am 2018;32:323-345.
51. Mera J, Vellozzi C, Hariri S, Carabin H, Drevets DA, Miller A, et al. Identification and clinical management of persons with chronic hepatitis C virus infection—Cherokee Nation, 2012-2015. MMWR Morb Mortal Wkly Rep 2016;65:461-466.